Search - tctmd.com

Displaying 661 - 680 of 1459

Sort: Relevancy | Date

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Industry News

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

May 08, 2017

News Industry News

LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients

May 05, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Industry News

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

April 26, 2017

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

Todd Neale

April 05, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

Advertisement

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

TCTMD’s Top 10 Most Popular Stories for May 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients

LivaNova Acquires Caisson Interventional, LLC

TCTMD’s Top 10 Most Popular Stories for April 2017

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

REVA to Expand FANTOM II Trial to More Complex Cases

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Live From Washington: ACC 2017, Day Two

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content